Scientists engineered stem cell-derived vesicles to deliver tumor-suppressive miR-124 into colorectal cancer cells, silencing ...

A novel CDH17-targeted antibody-drug conjugate called SCR-A008 achieved sustained tumor inhibition in gastric cancer PDX ...

Immunotherapy lands indication in combination with chemo for stage III dMMR tumors ...

Certain gut bacteria and their genes were linked to cancer outcomes and chemotherapy side effects. Credit: Shutterstock Gut bacteria may hold clues to cancer survival and chemotherapy side effects ...

The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...

More than 90% of oncologists who prescribe chemotherapy drugs such as fluoropyrimidines, thiopurines and irinotecan know genetic variants are linked to adverse events, and more than half perform ...

Roche RHHBY has secured yet another label expansion for its cancer immunotherapy Tecentriq (atezolizumab) in the United ...

The FDA has approved atezolizumab combined with chemotherapy for treating stage III dMMR colon cancer, enhancing post-surgery treatment options.

In the 712-patient ATOMIC trial, 36-month disease-free survival was 86% with Tecentriq plus chemotherapy, versus 76% with chemotherapy alone.

Dutch and US studies paint different pictures of systemic therapy use in metastatic pancreatic cancer, but differences in patient preferences and data sources complicate direct comparisons.

Dublin, Oct. 09, 2026 (GLOBE NEWSWIRE) -- "Actinic Keratosis - Market Insight, Epidemiology, and Market Forecast - 2036" has been added to ResearchAndMarkets.com's offering. The report provides a ...